Vasoreactivity in Carriers of Genetic Polymorphisms
NCT00160888
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
sodium nitroprusside, bradykinin, acetylcholine
Sponsor
Heidelberg University